FdaApplication

NDA 203697

Back to search

Identifiers

Properties

PropertyValue
applicant_namePLX PHARMA INC
application_typeNDA
approval_date2013-01-14

Products (2)

ProductActive ingredientStrengthDosage form
VAZALOREASPIRIN81MGCAPSULE;ORAL
VAZALOREASPIRIN325MGCAPSULE;ORAL

2 products